Frédéric Chevessier-Tünnesen

Title: Frédéric Chevessier-Tünnesen: Innovator in Biomedicine

Introduction

Frédéric Chevessier-Tünnesen is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of biomedicine, particularly in the development of therapeutic nucleic acids. With a total of 3 patents to his name, his work focuses on advancing medical treatments through innovative technologies.

Latest Patents

One of his latest patents is titled "Nucleic acids encoding CRISPR-associated proteins and uses thereof." This invention relates to the field of biomedicine and provides artificial nucleic acids, specifically RNAs, that encode CRISPR-associated proteins. The patent also includes a pharmaceutical composition and a kit-of-parts that incorporate these nucleic acids. Furthermore, it discusses the application of these artificial nucleic acids in medicine, particularly for the treatment and prophylaxis of diseases that can be addressed using CRISPR-associated proteins.

Career Highlights

Frédéric has worked with prominent companies in the biopharmaceutical sector, including CureVac SE and CureVac AG. His experience in these organizations has allowed him to contribute to groundbreaking research and development in therapeutic solutions.

Collaborations

Throughout his career, Frédéric has collaborated with esteemed colleagues such as Marion Poenisch and Thomas Schlake. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Frédéric Chevessier-Tünnesen stands out as an influential inventor in the realm of biomedicine, with a focus on CRISPR technology and therapeutic applications. His contributions continue to shape the future of medical treatments and innovations.